Close Menu

Aushon Biosystems

Near-term the deal gives Quanterix a CLIA lab while securing technologies that could improve assay multiplexing and support its longer term clinical goals.

The company has developed a series of cytokine immunoassays for its Ciraplex platform that it said can achieve sensitivity in the femtogram per ml range.

NEW YORK (GenomeWeb) – Aushon Biosystems has been building up its IP portfolio ahead of a planned expansion to its Cira immunoassay platform.

Title: Method of and system for applying blocking material to assay substrates.
Patent Number: 8,685,486
Filed: Aug. 10, 2011

Richard Smith, director of proteomics at Pacific Northwest National Laboratory, has been named recipient of the 2013 Award for a Distinguished Contribution in Mass Spectrometry by the American Society for Mass Spectrometry.

Illumina has appointed Charles Dadswell as its new senior vice president and general counsel. Dadswell replaces Christian Cabou, who has retired, and is responsible for all of the company's legal and IP matters.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics has appointed Michael Aicher to its board of directors. He is currently the CEO of Omicia. Previously, he was co-founder and CEO of the National Genetics Institute, a wholly owned subsidiary of Laboratory Corporation of America.

Agilent Technologies said this week that it has awarded its Agilent Thought Leader Award to Ronald DePinho, an oncologist at the University of Texas MD Anderson Cancer Center.

NEW YORK (GenomeWeb News) – Aushon BioSystems said today that it has appointed AH Diagnostics to be its exclusive distributor in Scandinavia, effective immediately.

BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.

Pages

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.